This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barrett-Connor, E. Articles by Goodman-Gruen, D. Search for Related Content PubMed PubMed Citation Articles by Barrett-Connor, E. Articles by Goodman-Gruen, D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

(Circulation. 1995;91:1757-1760.)
© 1995 American Heart Association, Inc.

Articles

Dehydroepiandrosterone Sulfate Does Not Predict Cardiovascular Death in Postmenopausal Women

The Rancho Bernardo Study

Elizabeth Barrett-Connor, MD; Deborah Goodman-Gruen, MD, PhD

From the Department of Family and Preventive Medicine, University of California, San Diego at La Jolla.

Background High levels of dehydroepiandrosterone sulfate (DHEAS) appear to be associated with a reduced risk of fatal cardiovascular disease (CVD) in men. We examined the association between baseline DHEAS levels and the 19-year CVD and ischemic heart disease (IHD) mortality rates in 942 postmenopausal women free of known heart disease at baseline.

Methods and Results The 199 CVD deaths and 102 IHD deaths were not related to baseline DHEAS levels. DHEAS was not related to body mass index, fasting plasma glucose, or family history of coronary heart disease, but significantly higher DHEAS levels were found in women who had elevated total or HDL cholesterol or blood pressure, were current smokers, or were nonusers of estrogen replacement therapy. After we adjusted for age, cholesterol, blood pressure, smoking, estrogen replacement therapy, obesity, fasting plasma glucose, and family history of heart disease, the relative risk of fatal CVD and IHD was 1.11 (95% confidence interval, 0.81 to 1.23) and 0.92 (95% confidence interval, 0.85 to 1.17), respectively, for a 50-µg/dL decrease in DHEAS.

Conclusions Although higher DHEAS levels were associated with several major CVD risk factors, they were unrelated to the risk of fatal CVD in women.

Key Words: cardiovascular disease • sex • aging • risk factors

This article has been cited by other articles:

				J. H. Page, J. Ma, K. M. Rexrode, N. Rifai, J. E. Manson, and S. E. Hankinson Plasma Dehydroepiandrosterone and Risk of Myocardial Infarction in Women Clin. Chem., July 1, 2008; 54(7): 1190 - 1196. [Abstract] [Full Text] [PDF]

				R. Karim, H. N. Hodis, F. Z. Stanczyk, R. A. Lobo, and W. J. Mack Relationship between Serum Levels of Sex Hormones and Progression of Subclinical Atherosclerosis in Postmenopausal Women J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 131 - 138. [Abstract] [Full Text] [PDF]

				M. R. Sowers, M. Jannausch, J. F. Randolph, D. McConnell, R. Little, B. Lasley, R. Pasternak, K. Sutton-Tyrrell, and K. A. Matthews Androgens Are Associated with Hemostatic and Inflammatory Factors among Women at the Mid-Life J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6064 - 6071. [Abstract] [Full Text] [PDF]

				C. Meyer, B. P. McGrath, J. Cameron, D. Kotsopoulos, and H. J. Teede Vascular Dysfunction and Metabolic Parameters in Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4630 - 4635. [Abstract] [Full Text] [PDF]

				C. Molinari, A. Battaglia, E. Grossini, D. A. S. G. Mary, C. Vassanelli, and G. Vacca The effect of dehydroepiandrosterone on regional blood flow in prepubertal anaesthetized pigs J. Physiol., May 15, 2004; 557(1): 307 - 319. [Abstract] [Full Text] [PDF]

				M. K. C. Ng, S. Nakhla, A. Baoutina, W. Jessup, D. J. Handelsman, and D. S. Celermajer Dehydroepiandrosterone, an adrenalandrogen, increases human foam cell formation: a potentially pro-atherogenic effect J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1967 - 1974. [Abstract] [Full Text] [PDF]

				K. K. Dhatariya and K. S. Nair Dehydroepiandrosterone: Is There a Role for Replacement? Mayo Clin. Proc., October 1, 2003; 78(10): 1257 - 1273. [Abstract] [PDF]

				C Molinari, A Battaglia, E Grossini, D A S G Mary, C Vassanelli, and G Vacca The effect of dehydroepiandrosterone on coronary blood flow in prepubertal anaesthetized pigs J. Physiol., June 15, 2003; 549(3): 937 - 944. [Abstract] [Full Text] [PDF]

				S. H. Golden, A. Maguire, J. Ding, J. R. Crouse, J. A. Cauley, H. Zacur, and M. Szklo Endogenous Postmenopausal Hormones and Carotid Atherosclerosis: A Case-Control Study of the Atherosclerosis Risk in Communities Cohort Am. J. Epidemiol., March 1, 2002; 155(5): 437 - 445. [Abstract] [Full Text] [PDF]

				D. P. Trivedi and K. T. Khaw Dehydroepiandrosterone Sulfate and Mortality in Elderly Men and Women J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4171 - 4177. [Abstract] [Full Text] [PDF]

				L. Mazat, S. Lafont, C. Berr, B. Debuire, J.-F. Tessier, J.-F. Dartigues, and E.-E. Baulieu Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: Relationship to gender, subjective health, smoking habits, and 10-year mortality PNAS, June 20, 2001; (2001) 121177998. [Abstract] [Full Text] [PDF]

				H. A. Feldman, C. B. Johannes, A. B. Araujo, B. A. Mohr, C. Longcope, and J. B. McKinlay Low Dehydroepiandrosterone and Ischemic Heart Disease in Middle-aged Men: Prospective Results from the Massachusetts Male Aging Study Am. J. Epidemiol., January 1, 2001; 153(1): 79 - 89. [Abstract] [Full Text] [PDF]

				G. A. Laughlin and E. Barrett-Connor Sexual Dimorphism in the Influence of Advanced Aging on Adrenal Hormone Levels: The Rancho Bernardo Study J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3561 - 3568. [Abstract] [Full Text]

				Y. Moriyama, H. Yasue, M. Yoshimura, Y. Mizuno, K. Nishiyama, R. Tsunoda, H. Kawano, K. Kugiyama, H. Ogawa, Y. Saito, et al. The Plasma Levels of Dehydroepiandrosterone Sulfate Are Decreased in Patients with Chronic Heart Failure in Proportion to the Severity J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1834 - 1840. [Abstract] [Full Text]

				S. Kiechl, J. Willeit, E. Bonora, S. Schwarz, and Q. Xu No Association Between Dehydroepiandrosterone Sulfate and Development of Atherosclerosis in a Prospective Population Study (Bruneck Study) Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1094 - 1100. [Abstract] [Full Text] [PDF]

				V V. Roger, S J Jacobsen, S A Weston, and S E Gabriel Sex differences in the epidemiology and outcomes of heart disease: population-based trends Lupus, June 1, 1999; 8(5): 346 - 350. [Abstract] [PDF]

				C. Berr, S. Lafont, B. Debuire, J.-F. Dartigues, and E.-E. Baulieu Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: A French community-based study PNAS, November 12, 1996; 93(23): 13410 - 13415. [Abstract] [Full Text] [PDF]

				D. Pratico and G. A. FitzGerald Testosterone and Thromboxane : Of Muscles, Mice, and Men Circulation, June 1, 1995; 91(11): 2694 - 2698. [Full Text]

				L. Mazat, S. Lafont, C. Berr, B. Debuire, J.-F. Tessier, J.-F. Dartigues, and E.-E. Baulieu Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: Relationship to gender, subjective health, smoking habits, and 10-year mortality PNAS, July 3, 2001; 98(14): 8145 - 8150. [Abstract] [Full Text] [PDF]